2-[8-[2-(3a,7a-dihydro-1H-indol-3-yl)ethylamino]-6-(5-fluoro-3-pyridinyl)imidazo[1,2-a]pyridin-3-yl]propan-1-ol
C25H26FN5O — CID 146523479
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[8-[2-(3a,7a-dihydro-1H-indol-3-yl)ethylamino]-6-(5-fluoro-3-pyridinyl)imidazo[1,2-a]pyridin-3-yl]propan-1-ol
2-[8-[2-(3a,7a-dihydro-1H-indol-3-yl)ethylamino]-6-(5-fluoro-3-pyridinyl)imidazo[1,2-a]pyridin-3-yl]propan-1-ol (PubChem CID 146523479) has the molecular formula C25H26FN5O and a molecular weight of 431.52 g/mol. Its IUPAC name is 2-[8-[2-(3a,7a-dihydro-1H-indol-3-yl)ethylamino]-6-(5-fluoro-3-pyridinyl)imidazo[1,2-a]pyridin-3-yl]propan-1-ol.
Molecular Properties
| Compound Name | 2-[8-[2-(3a,7a-dihydro-1H-indol-3-yl)ethylamino]-6-(5-fluoro-3-pyridinyl)imidazo[1,2-a]pyridin-3-yl]propan-1-ol |
|---|---|
| PubChem CID | 146523479 |
| Molecular Formula | C25H26FN5O |
| Molecular Weight | 431.52 g/mol |
| Exact Mass | 431.21 |
| IUPAC Name | 2-[8-[2-(3a,7a-dihydro-1H-indol-3-yl)ethylamino]-6-(5-fluoro-3-pyridinyl)imidazo[1,2-a]pyridin-3-yl]propan-1-ol |
| SMILES | CC(CO)c1cnc2c(NCCC3=CNC4C=CC=CC34)cc(-c3cncc(F)c3)cn12 |
| InChI | InChI=1S/C25H26FN5O/c1-16(15-32)24-13-30-25-23(9-19(14-31(24)25)18-8-20(26)12-27-10-18)28-7-6-17-11-29-22-5-3-2-4-21(17)22/h2-5,8-14,16,21-22,28-29,32H,6-7,15H2,1H3 |
| InChIKey | WGNDSZQRUYZOMO-UHFFFAOYSA-N |
| XLogP | 4.03 |
| TPSA | 74.48 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 431.52 |
| LogP ≤ 5 | 4.03 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146523479 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.